All Stories

  1. Analysis of the trends of polypharmacy and high‐dose prescriptions in Japan

    Article • Asia-Pacific Psychiatry, September 2021, Wiley

    naotaka shinfuku

  2. Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region

    Article • Asia-Pacific Psychiatry, May 2020, Wiley

    naotaka shinfuku

  3. Clinical Characteristics of Bipolar Disorder Patients with Mood Stabilizer-Induced Cognitive Side Effects findings from the REAP-BD Survey in Korea

    Article • Journal of Korean Neuropsychiatric Association, January 2020, Korean Neuropsychiatric Association (KAMJE)

    naotaka shinfuku

  4. Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia

    Article • Nordic Journal of Psychiatry, June 2019, Taylor & Francis

    Seon-Cheol Park, Dr Adarsh Tripathi, Takahiro Kato, naotaka shinfuku, Dr Yong Chon Park, Toshiya Inada

  5. Establishing the cut-off score for aggression on the Brief Psychiatric Rating Scale-Excited Component (BPRS-EC) in schizophrenia patients

    Article • Psychiatry and Clinical Psychopharmacology, June 2019, Taylor & Francis

    Seon-Cheol Park, Takahiro Kato, naotaka shinfuku, Dr Yong Chon Park, Eunyoung Jang

  6. Physical comorbidities in older adults receiving antidepressants in Asia

    Article • Psychogeriatrics, July 2018, Wiley

    naotaka shinfuku

  7. Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics

    Article • Psychiatry and Clinical Neurosciences, June 2018, Wiley

    Dr Yong Chon Park, naotaka shinfuku

  8. A comparison of clinical characteristics of older adults treated with antidepressants in general and psychiatric hospitals in Asia

    Article • Psychogeriatrics, April 2017, Wiley

    naotaka shinfuku